InMed Pharmaceuticals to begin trading on Toronto Stock Exchange
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
InMed Pharmaceuticals Inc. said it received the final approval to list its common shares on the Toronto Stock Exchange.
The Vancouver, British Columbia-based medical cannabis company's shares will start trading on the exchange from March 26, under the symbol IN.
Concurrently on March 26, InMed's shares will be delisted from the Canadian Securities Exchange.
